Chargement en cours...
NEOADJUVANT LENVATINIB IN ADVANCED UNRESECTABLE MEDULLARY THYROID CARCINOMA: A CASE REPORT
OBJECTIVE: Medullary thyroid carcinoma, a rare form of thyroid cancer, is typically managed with surgical excision. However, in patients with locally-invasive tumors, an aggressive surgical attempt may result in unnecessary morbidity. Neoadjuvant tyrosine kinase inhibition has been utilized to downs...
Enregistré dans:
| Publié dans: | AACE Clin Case Rep |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Association of Clinical Endocrinologists
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7282158/ https://ncbi.nlm.nih.gov/pubmed/32524015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0365 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|